This statistical study indicates that 1) the survival rate of breast cancer patients with in situ neoplasm is more than one who is not initially supported by invasive carcinoma, and 2) in the case of existence of the both in situ neoplasm and invasive malignancy, after the 4th year, the ...
Age is another critical breast cancer risk factor. Breast cancer may occur at any age, though the risk of breast cancer increases with age. The average woman at 30 years of age has one chance in 280 of developing breast cancer in the next 10 years. This chance increases to one in 70 f...
Using recent developments in capture-recapture modeling, we analyzed the adult survival pattern of an Alpine ibex (Capra ibex ibex) population recently established in the northern Alps of France. Survival rates varied little over time and did not differ between the sexes. The survival rate was 0.9...
The weighted 10-year breast cancer-specific survival for low-grade DCIS was comparable in the surgical and nonsurgical arms (98.8% vs. 98.6%; HR = 0.88; 95% CI, 0.21-3.71). For OS, the 10-year survival rate in the surgery group was 90%,...
Neck control rate was 97% in SLN negative and 95% in SLN positive patients. They concluded that SNB is able to reduce the risk of occult lymph node metastases in T1/T2 oral cancer patients from 40% to 8%, and enables excellent control of the neck. Read more View chapterExplore book ...
doi:10.1038/sj.bjc.6601114 www.bjcancer.com & 2003 Cancer Research UK Keywords: CD1a; dendritic cells; breast cancer; survival Breast cancer is the most common terminal cancer in women in developed Western societies (Australian Bureau of Statistics, 2002). The overall survival rate at 5 years ...
Pure tubular carcinoma (PTC) is a favourable histologic subtype of breast cancer with a low rate of lymph node involvement. This study was initiated to assess the sentinel lymph node (SLN) detection rate and the rate of ax... M Dejode,F Dravet,C Sagan,... - 《Cancer Research》 被引...
The relapse-free survival (RFS) rate was 77% in the cohort of patients who received Orca-T vs 62% in the cohort of patients who received PTCy (HR, 0.5; 95% CI, 0.3-0.9). Furthermore, the non-relapse mortality (NRM) rates with Orca-T and PTCy were 3% and 16%, respectively (HR...
Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function AS Beltran1, LM Graves1 and P Blancafort1,2 Basal-like breast tumors are aggressive cancers associated with high proliferation and ...
“[KEYNOTE-522] was a positive trial for its 2 primary end points—short-term pathological complete response [(pCR) rate] and event-free survival [EFS]—and most importantly, [data] demonstrated that [the pembrolizumab regimen] reduced the risk of death by 34%,” lead study author Peter ...